Company: SPEG
Filing Date: 2025-01-21
Form Type: S-1
Source: 0001213900-25-005097
Chunk: 330

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-01-21
Form: S-1
Chunk 330
---
 units if the underwriters’ over -allotmentoption is exercised in full and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Up to 562,500 of these shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentis exercised.

II-1

Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our sponsor is to act as the company’s sponsor in connection with this offering. The limited liability company agreement of our sponsor provides that its membership interests may only be transferred to our officers or directors or other persons affiliated with our sponsor, or in connection with estate planning transfers. Our sponsor and Roth, the representative of the underwriters, have committed, pursuant to written agreements, to purchase from us an aggregate of 550,000 private placement units (or 606,250 if the underwriters’ over -allotmentoption is exercised in full) at $10.00 per private unit (for an aggregate purchase price of $5,500,000 (or $6,062,500 if the underwriters’ over -allotmentoption is exercised in full)). Of those 550,000 private placement units, our sponsor has agreed to purchase 350,000 private placement units (or 406,250 units if the underwriters’ over -allotmentoption is exercised in full) and Roth has agreed to purchase 200,000 of those private placement units. The private placement units will also be worthless if we do not complete our initial business combination. This purchase will take place on a private placement basis simultaneously with the completion of our initial public offering. This issuance will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were paid with respect to such sales. Item 16. Exhibits and Financial Statement Schedules. Exhibit Index

| Exhibit No. |     | Description                                                                                                                     |
| 1.1**       |     | Form of Underwriting Agreement.                                                                                                 |
| 3.1*        |     | Memorandum and Articles of Association.                                                                                         |
| 3.2*        |     | Amended and Restated Memorandum and Articles of Association.                                                                    |
| 3.3**       |     | Form of Second Amended and Rest